Latest Regulatory News

Minbos Resources Limited reported a challenging quarter with significant cash outflows but plans a $1 million share purchase plan to bolster its funding position.

Tissue Repair’s December quarter update reveals a cautious path forward for its Phase 3 TR987 trial amid slow patient recruitment, while its TR Pro+ product line gains momentum through a new distributor partnership and upcoming product launches.

Bubs Australia reports a 14% increase in half-year revenue, powered by a 47% jump in US sales, while other regions face challenges. The company remains optimistic about FDA approval and market recovery in H2 FY26.

Recce Pharmaceuticals progresses its Phase 3 diabetic foot infection trial in Indonesia, reports promising preclinical data for inhaled RECCE 327, and secures significant R&D funding and patent protection.

Clime Investment Management appoints John Abernethy as Director of Investments, signalling a renewed focus on investment philosophy and client outcomes. Despite fund closures and regulatory challenges, the company reports improved fund returns and a promising interim profit outlook.

Identitii Limited has secured five new customer contracts worth $250k and seen a four-fold increase in usage of its BNDRY platform, even as its capital raising efforts face delays due to a Takeovers Panel application.

Eastern Resources Limited reports steady progress on its Marengo Gold Project farm-in agreement despite ministerial approval delays, alongside ongoing environmental assessments at Nowa Nowa and a director resignation.

Adherium Limited has exceeded its 2025 shipment goals for its Hailie Smartinhaler devices, driven by rapid growth in remote patient monitoring activations and improved US Medicare reimbursement policies.

Australian Rare Earths Limited has raised approximately $6 million through a strategic share placement to advance its Koppamurra Rare Earths Project, underpinning its role in diversifying global rare earth supply chains.

Zeus Resources has made significant progress in its December quarter activities, advancing trenching at the Casablanca Antimony Project and confirming gold and lithium anomalies at Blue Hill. The company also reported stable cash reserves and key corporate developments following its 2025 AGM.

Peregrine Gold has identified a second large-scale, high-grade Channel Iron Deposit near Newman, Western Australia, while expanding its Rocklea Gold Project footprint and maintaining a strong cash position.

Provaris Energy has made significant strides in hydrogen and liquid carbon dioxide storage technologies, reinforcing key partnerships and securing funding to meet critical 2026 milestones.